Reference
Janczewska E, et al. The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study. BMC Infectious Diseases 18: 580, No. 1, 16 Nov 2018. Available from: URL: http://doi.org/10.1186/s12879-018-3465-2 - Poland
Rights and permissions
About this article
Cite this article
Antivirals. Reactions Weekly 1739, 45 (2019). https://doi.org/10.1007/s40278-019-57685-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57685-5